Featured
PodcastTalking with Dr. Anjana Pillai About Liver Cancer and Navigating Early Career
Adam and Alex talk with Dr. Anjana Pillai about navigating early career and what’s new in HCC.
Adam Winters
Alex VogelLatest
Evidence CornerIs liver transplantation a viable treatment for intrahepatic cholangiocarcinoma?
Can liver transplantation be an effective therapy for intrahepatic cholangiocarcinoma?
Jennifer Wang
The Why? SeriesWhy do we use non-selective beta-blockers in cirrhosis? – Part 1
In the first post from new LFN author Anahita Rabiee, we are gifted an authoritative review on the Whys and Hows of beta-blockade in decompensated cirrhosis! You definitely want to read this one!
Anahita RabieePodcastTalking with Dr. Anjana Pillai About Liver Cancer and Navigating Early Career
Adam and Alex talk with Dr. Anjana Pillai about navigating early career and what’s new in HCC.
Alex VogelAdam Winters
Clinical PearlsWhat happens to the liver when blood vessels go rogue
A 40 year-old female with a history of recurrent nosebleeds presents to hepatology clinic for persistently elevated liver enzymes. Lab work-up reveals total bilirubin 1.0 mg/dL, alkaline phosphatase 247 U/L, ALT 90 U/L, AST 53 U/L, INR 1.0, hemoglobin 7.5 g/dL and platelet count 250 K/cmm. Iron studies reveal ferritin 12 ng/mL, iron 20 ug/dL, transferrin saturation 5%.
On physical exam she has multiple small telangiectasias on her trunk, upper extremities, lips and oral mucosa. Non-tender hepatomegaly is noted on abdominal exam.
Her mother also suffers from recurrent nosebleeds, iron deficiency anemia and has similar telangiectasias on her lips and trunk.
What is not recommended as part of the work-up for this condition?
Jessica Musto